BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26001119)

  • 1. FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
    Pasha MA; Marcus C; Fakhry C; Kang H; Kiess AP; Subramaniam RM
    AJR Am J Roentgenol; 2015 Aug; 205(2):W150-61. PubMed ID: 26001119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
    Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
    Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
    Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
    Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
    J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative evaluation of patients with squamous cell carcinoma of the oral cavity: fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and ultrasonography versus histopathology.
    Sugawara C; Takahashi A; Kubo M; Otsuka H; Ishimaru N; Miyamoto Y; Honda E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Oct; 114(4):516-25. PubMed ID: 22986248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT: Emphasis and current utility in oral cancer.
    Routray S; Shankar AA
    Oral Oncol; 2012 Nov; 48(11):e42. PubMed ID: 22868079
    [No Abstract]   [Full Text] [Related]  

  • 14. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PET/CT in the management of cervical cancer.
    Mirpour S; Mhlanga JC; Logeswaran P; Russo G; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2013 Aug; 201(2):W192-205. PubMed ID: 23883234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
    Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity.
    Goerres GW; Schmid DT; Grätz KW; von Schulthess GK; Eyrich GK
    Oral Oncol; 2003 Sep; 39(6):547-51. PubMed ID: 12798396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.